Preview

Russian Journal of Cardiology

Advanced search

Heart failure and anemia in patients with acute myocardial infarction

Abstract

In-hospital management of myocardial infarction was analyzed for 150 patients (54 women). Mean age was 59, 6+1, 1 years for men, and 69, 2+1, 1 years for women. All participants underwent thrombolysis. Patients with severe associated pathology and hemorrhage in anamnesis were excluded from the study. Red blood cell count and hemoglobin (Hb) level in capillary blood were measured at admission. Death, acute heart failure, left ventricular dysfunction (by echocardiography criteria) were registered. At discharge, anemia was observed in 42 participants. Individuals, who died from cardiogenic shock, had lowest Hb levels (128, 6 ± 4, 1 g/l), comparing to participants, who died from other causes (135, 3 ± 5, 7 g/l), and survivors (133, 1+1, 2 g/l). Anemia was an independent predictor of middle-term in-hospital mortality (odds ratio 4, 7; p < 0, 05). Predischarge ejection fraction was directly linked to Hb level at admission (t = 2, 34; p < 0, 05).

About the Authors

T. Yu. Kalyuta
Саратовский государственный медицинский университет
Russian Federation


R. E. Lubeznov
Саратовский государственный медицинский университет
Russian Federation


O. V. Orlikova
Саратовский государственный медицинский университет
Russian Federation


Yu. G. Schwartz
Саратовский государственный медицинский университет
Russian Federation


References

1. Арутюнов Г.П. Анемия у больных с ХСН. // Сердечная недостаточность. 2003. Т. 4, № 5. С. 224-228.

2. Дэнхэм М. Дж., Чанарин И. Болезни крови у пожилых: Пер. с англ. М.: Медицина, 1989. 352 с.

3. Кузьмин В.П. Гомеостаз при остром нарушении коронарного кровообращения (1970-2000 гг.) и пути улучшения диагностики на догоспитальном этапе: Автореф. дис.... канд. мед. наук. Самара, 2003. 23 с.

4. Сыркин А.Л. Инфаркт миокарда: 3-е изд., перераб. и доп. М.: Медицинское информационное агентство, 2003. 466 с.

5. Зубкова А.А. Ближайшие и отдаленные последствия тромболитической терапии у больных острым инфарктом миокарда: Автореф. дис.... канд. мед. наук. Ростов-на-Дону, 2003. 21 с.

6. Al Falluji N., Lawrence-Nelson J., Kostis J.B., et al. Myocardial Infarction Data Acquisition system (MIDAS #8) Study Group. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. // Am Heart J. 2002. Vol. 144. P. 636-41.

7. Antman E., Cooper H., McKinlay S. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomized controlled trial. // Lancet. 2002. Vol. 360. P. 1955-1963.

8. Boneu В., Fernandez F. The role of the hematocrit in bleeding. // Transfus Med Rev. 1987. Vol. 1, N 3. P. 182-185.

9. De Valk В., Marx J.J. Iron, atherosclerosis, and ischemic heart disease. // Arch Intern Med. 1999. Vol. 159. P. 1542.

10. Kleiman N.S., White H.D., Ohman E.M., et al. Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. // Circulation. 1994. Vol. 90. P. 2658-2665.

11. Kupari M., Lindroos M., Iivanainen A.M., et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. // J Intern Med. 1997. Vol. 241. P. 387-394.

12. Goodnough L.T., Bach R.G. Anemia, Transfusion, and Mortality. // The New England Journal of Medicine. 2001. Vol. 345. P. 1272-1274.

13. Salonen J., Nyyssonen K., Korpela H. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnishmen. // Circulation. 1992. Vol. 86. P. 803-811.

14. Marchais S.J., Guerin A.P., Pannier В., London G.M. Pathophysiology of anaemia: focus on the heart and blood vessels. // Nephrol Dial Transplant. 2000. Vol. 15. P. 14-18.

15. White H. The Hirulog and Early Reperfusion or Occlusion (HERO-2) Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. // Lancet. 2001. Vol. 358. P. 1855-1863.


Review

For citations:


Kalyuta T.Yu., Lubeznov R.E., Orlikova O.V., Schwartz Yu.G. Heart failure and anemia in patients with acute myocardial infarction. Russian Journal of Cardiology. 2005;(1):16-19. (In Russ.)

Views: 526


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)